Doses of Wegovy - Search News

Medicare targets popular weight loss drugs Ozempic, Wegovy

Tripling Wegovy dosage leads to more weight loss, Novo Nordisk trial shows

Tripling the dosage of the Wegovy weight-loss drug leads to more weight loss, Novo Nordisk said Friday. The Danish drugmaker announced results from a Phase 3B trial of semaglutide at a 7.2 milligram dosage,

USA TODAY on MSN · 6h

Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.

Reuters on MSN · 3h

Explainer-What Wegovy's inclusion in Medicare price negotiation means for patients, company

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk's blockbuster weight-loss drug Wegovy.Here's

High-dose Wegovy leads to substantial weight loss in trial

Wall Street Journal · 8h

Wegovy at Higher Dose Achieves Greater Weight Loss in Trial

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, without experiencing an increase in side effects.

STAT · 8h

High-dose Wegovy leads to substantial weight loss in trial, but falls short of Zepbound

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than what’s been seen with Zepbound.

Gizmodo · 58m

Meet ‘Super’ Ozempic: Higher Dose Semaglutide Leads to Even Greater Weight Loss In Major Trial

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

5hon MSN

Novo’s Wegovy Trails Lilly’s Rival in High-Dose Study

Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new ...

6hon MSN

Ozempic, Wegovy and other drugs are among 15 selected for Medicare’s price negotiations

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

BioPharma Dive2h

Novo shares high-dose Wegovy results; Amgen, AstraZeneca drugs get expanded OKs

A high-dose form of Novo’s obesity drug led to 20% weight loss over 72 weeks. Meanwhile, Atara got a complete response letter and Boehringer reported a Phase 3 failure.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Medicare targets popular weight loss drugs Ozempic, Wegovy

High-dose Wegovy leads to substantial weight loss in trial

Trending now

Related topics